Moderna's COVID vaccine gets full US approval for at-risk children aged 6 months and older
Tired of too many ads? go ad free now
The move marks a shift in federal policy under Health and Human Services Secretary Robert F. Kennedy Jr., who has led a controversial effort to scale back universal access to pediatric COVID shots.
The Food and Drug Administration's decision, announced Thursday, means that healthy children in this age group will no longer have routine access to the vaccine unless it is prescribed off-label. Moderna's shares rose more than 4% in early trading in New York following the announcement.
Under emergency use authorization during the pandemic, COVID-19 vaccines from Moderna and Pfizer were made widely available to all children. But Kennedy, a longtime vaccine skeptic, has reversed course. In 2021, he petitioned the FDA to revoke temporary approval for children's vaccines, citing low risk of severe illness in healthy children. Now, the vaccine's full approval ensures it remains available for high-risk kids, but also restricts broader access.
What are the risks of SPIKEVAX?
For most people, getting the SPIKEVAX COVID-19 vaccine is safe and simple. But like any vaccine, there are some rare risks you should know about.
There's a very small chance of having a serious allergic reaction, usually within a few minutes to an hour after the shot. That's why your doctor or nurse may ask you or your child to wait for a short time after getting vaccinated—just to be safe.
As per the official website of Moderna, signs of a serious allergic reaction may include:
Difficulty breathing
Swelling of the face or throat
A fast or racing heartbeat
A rash all over the body
Dizziness or weakness
In rare cases, some people—mostly boys and young men between 12 and 24 years old—have developed myocarditis (inflammation of the heart muscle) or pericarditis (inflammation of the lining around the heart) after getting an mRNA COVID-19 vaccine like SPIKEVAX.
Tired of too many ads? go ad free now
If you or your child experiences any of the following symptoms within two weeks of the vaccine, it's important to see a doctor right away:
Chest pain
Shortness of breath
A fast, fluttering, or pounding heartbeat
In children, signs to watch for can include chest pain, shortness of breath, pounding heartbeat, fainting, being unusually tired or irritable, poor feeding, stomach pain, vomiting, or cool, pale skin.
What are the possible side effects of SPIKEVAX?
Common side effects around the injection site: pain or tenderness, redness, swelling or firmness, and swollen lymph nodes in the same arm or sometimes in the groin
General side effects: feeling tired or sleepy, headache, muscle or joint pain, chills or fever, nausea or vomiting, rash, irritability or crying (especially in young children) and loss of appetite.
In some cases, people have also reported fainting or febrile seizures (seizures caused by a fever). While these are less common, it's helpful to be aware of them.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
NDTV
40 minutes ago
- NDTV
COVID-19 May Trigger Alzheimer's-Like Protein Buildup In Brain And Eyes, Study Finds
New research suggests that COVID-19 can lead to protein build-up similar to that seen in Alzheimer's patients, not just in the brain but also in the eyes. Elevated amyloid beta levels were found in the retinal tissue of people who had COVID-19, similar to Alzheimer's-like retinal conditions. Notably, Amyloid beta buildup is associated with Alzheimer's disease. Researchers analysed two proteins, neuropilin-1 (NRP1) and angiotensin-converting enzyme 2 (ACE2). The NRP1 protein may serve as an entry point for viruses into human eyes and brains. Researchers found that introducing an NRP1 inhibitor countered the amyloid beta increase caused by COVID-19's spike protein. The study, led by Yale University and published in Science Advances, sheds light on COVID-19 brain fog, which was a commonly reported symptom following infection. The researchers believe that amyloid beta may act as a bodyguard for the brain, indicating underlying danger. "There is growing evidence linking COVID-19 and brain fog, a commonly reported symptom following infection," senior author Brian Hafler, ophthalmologist at Yale School of Medicine, said as quoted by Science Alert. "While the mechanisms of brain fog after COVID-19 are not fully understood, scientists have found that SARS-CoV-2 can induce amyloid beta accumulation in the central nervous system." The research team is conducting clinical studies to determine if COVID-19 increases the long-term risk of developing Alzheimer's disease, to explore NRP1 inhibitors as potential therapeutics. The involvement of NRP1 in amyloid beta aggregation provides a specific molecular target for future investigation. Other viruses may trigger similar amyloid beta buildups, as there's a need for further research. This study contributes to understanding the complex relationship between COVID-19 and neurological health. "Our study showed that exposure to SARS-CoV-2, in particular spike protein, can lead to the formation of amyloid beta aggregates in both human retinal tissue and retinal organoids," Hafler says.
Time of India
3 hours ago
- Time of India
India-UK FTA: Zero duty to boost India's generic drug, medical device exports to Britain
Exports of generic medicines and medical devices like X-ray systems and surgical instruments will get a boost as Britian has agreed upon zero duty under the free trade agreement. The trade agreement between India and the UK was singed on Thursday in London in the presence of Prime Minister Narendra Modi and UK premier Keir Starmer. Explore courses from Top Institutes in Please select course: Select a Course Category Finance Design Thinking Degree others PGDM Leadership Operations Management Artificial Intelligence Management Data Science Product Management Digital Marketing MCA Cybersecurity Others healthcare Public Policy CXO Project Management Healthcare MBA Data Science Skills you'll gain: Duration: 9 Months IIM Calcutta SEPO - IIMC CFO India Starts on undefined Get Details Skills you'll gain: Duration: 7 Months S P Jain Institute of Management and Research CERT-SPJIMR Fintech & Blockchain India Starts on undefined Get Details Skills you'll gain: Duration: 9 Months IIM Calcutta SEPO - IIMC CFO India Starts on undefined Get Details Skills you'll gain: Duration: 9 Months IIM Calcutta SEPO - IIMC CFO India Starts on undefined Get Details Skills you'll gain: Duration: 7 Months S P Jain Institute of Management and Research CERT-SPJIMR Fintech & Blockchain India Starts on undefined Get Details "Significant share of medical devices like surgical instruments, diagnostic equipments, ECG machines, X-Ray systems will not attract any duty," PTI reported quoting a commerce ministry official. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like Cardiologist: The Best Method for a Flat Stomach After 50 (It's Genius!) Lulutox Undo The deal will reduce costs for Indian med-tech companies and make products more competitive in the UK market. "Given the UK's shift away from reliance on Chinese imports post-Brexit and COVID-19, Indian manufacturers are poised to emerge as a favoured, cost-effective alternative, especially with zero-duty pricing for medical devices," the official told PTI. Live Events The commerce ministry has said that zero tariff provisions under the FTA are expected to significantly enhance the competitiveness of Indian generics in the UK market, which remains India's largest pharmaceutical export destination in Europe. Currently, India exports $23.31 billion globally and the UK imports nearly $30 billion, but Indian pharma accounts for under $1 billion, indicating significant headroom for growth. The pharma sector has only 56 tariff lines, which is just 0.6 per cent of the total, the document stated. Despite the small representation, pharmaceutical sector holds high value and strategic importance, especially in global trade, the document stated. India's pharmaceutical industry is the world's third largest by volume and 14th largest in terms of value. The sector's exports rose 10 per cent year-on-year to $30.5 billion in FY 2024-25. The industry is leading in the manufacture of high-quality generic drugs at competitive prices over the last 30 years. India is the largest supplier of generic medicines with a 20 per cent share in the global supply by manufacturing 60,000 different generic brands across 60 therapeutic categories. Indian products are shipped to over 200 countries around the globe, with Japan, Australia, West Europe and the US as the main destinations. The current market size of the medical devices sector in India is estimated to be $11 billion and expected to reach $50 billion by 2030.
Fashion Value Chain
7 hours ago
- Fashion Value Chain
Why More Patients Are Choosing This Game-Changing Hip Replacement
For over three years, a chemical engineer in his early 50s, working in Malaysia, lived with pain that gradually stole his mobility, independence, and peace of mind. Every step reminded him of what he had lost – long walks, work trips, even simple tasks like tying his shoelaces. His limp in the right leg wasn't just physical; it weighed heavily on his spirit too. Dr. Narayan Hulse – A leading orthopaedic surgeon specializing in robotic joint replacement Determined to find a solution, he consulted multiple surgeons in Delhi and Mumbai, but none could offer lasting relief. Doctors told him he had Avascular Necrosis (AVN) – a condition that cuts off blood supply to the hip bone, causing it to weaken and collapse. His problems began after a COVID-19 infection, and though he underwent two surgeries in Mumbai, neither brought relief. As an engineer, he believed in science and precision. He had done his research. He wasn't afraid of surgery – but he was tired of failure. Then, he came across a therapy he hadn't heard much about before: Robotic Direct Anterior Hip Replacement (DAA). That decision changed everything. A Modern Twist to a Classic Surgery Total hip replacement isn't new. It has helped millions walk again. But what's different about the Robotic Direct Anterior Approach is how it's done – and what it avoids. Most traditional hip replacements access the joint from the back (posterior) or side (lateral), often cutting through or detaching essential muscles. This could lead to more pain, a longer recovery, and a higher risk of dislocation. With the DAA technique, the surgeon enters from the front of the hip, sliding between muscles rather than cutting through them. This muscle-sparing approach, combined with robotic guidance, makes the surgery less invasive, highly precise, and allows for faster healing. It is becoming a preferred approach worldwide for these reasons. Precision Meets Recovery: The Power of Robotic Assistance Robotic technology does not replace the surgeon – it enhances the surgeon's accuracy. Before surgery, a 3D model of the patient's hip is created. This helps the surgeon decide the exact size, position, and angle of the implant needed. During the operation, the robot provides real-time feedback, ensuring the implant is placed exactly where it should be. This minimizes errors such as leg length mismatch and poor alignment – common concerns in traditional surgeries. The Engineers Turnaround For our 53-year-old patient, the first robotic DAA surgery on his left hip involved an incision of just about 8 cm – less than half the size of traditional cuts. Because no major muscles were cut, he was able to stand and walk with support on the very same day. Four months later, his second hip was replaced using the same method. His recovery was smooth – no pain, no limping, no complications. 'After living with discomfort for so long, I couldn't believe how quickly I was able to move again,' he said. 'This therapy didn't just fix my hips – it gave me back the rhythm of my life.' What Makes Robotic DAA Therapy Stand Out Faster Recovery with Less Pain: Since no major muscles are cut, your body heals faster and with less discomfort. Smaller Incision, Less Scarring: The 8 cm cut means minimal skin and tissue damage. Better Accuracy with Robotic Help: The robot helps the surgeon position the new joint perfectly. Walk Sooner: Most patients can walk with support within hours of surgery. Balanced Leg Length: Robotic precision ensures both legs are equal in length – avoiding limping. Lasting Results: Accurate implant positioning improves durability and lowers the chance of needing revision surgery. Expert Insight Dr. Narayan Hulse, a leading orthopedic surgeon specializing in robotic joint replacement, explains, 'Robotic DAA therapy combines the best of both worlds – a minimally invasive front-access approach and the unmatched precision of robotic technology. The result is a safer, faster, and more natural recovery for patients. However, surgeons should train themselves properly and hospitals should acquire the required technology and instrumentation to provide this service to needy patients.' The Takeaway This isn't just about a new kind of surgery – it's about a new kind of life after surgery. For patients living with AVN, arthritis, or chronic hip pain, Robotic DAA Hip Replacement therapy offers not just hope but a real, science-backed solution. If walking has become a struggle and pain your new normal, know that you have options. Thanks to advancements like Robotic DAA, those options are better, faster, and more reliable than ever before. If you or a loved one suffers from chronic hip pain, consult an orthopedic specialist to learn if Robotic DAA Hip Replacement is right for you.
